Jan 10, 2014 ... PhaseRx is privately held RNA therapeutics company developing treatments for orphan liver disease. The Company is utilizing its proprietary ...
Wyle Science, Technology & Engineering Group. Houston, TX. Joseph P. Dervay, MD. NASA Johnson Space Center, Houston, TX. Michael L. Gernhardt, PhD.
Michael A. Assel, Ph.D., is a Clinical Professor of Pediatrics in the Children's Learning Institute at the University of Texas Health Science Center at Houston.
Michael speaks on Houston Matters about retirement and adjusting to the changes. From the HoustonMatters.org website. Adjusting to retirement can be a ...
HOUSTON – (Jan. 5, 2016) – Michael R. Blackburn, Ph.D., a nationally recognized lung disease researcher and academic leader, has been appointed ...
Michael Ryan, a professor of communication at the University of Houston, has taught media writing, research methods, communication theory, public relations, ...
Allison Doupe, M.D./Ph.D. DCS, B.Sc., McGill University ... Michael Shepley, M.D. /Ph.D. B.S., Northeastern ... E. Houston Warren, Ph.D. A.B., Harvard College.
M.S. 2004. Program Manager for the Houston Regional Prepardness Initiative, Houston, TX ... Kevin Borden. Ph.D. 2008, M.S. 2004 ... Ph.D. 1998. DCS Corporation, Huntsville, AL ... M.S. 2000. Michael Baker Corporation, Washington D.C. ...
2001, The University of Texas Health Science Center, Houston, TX, MD, PhD, ...... the MHC class 1 cytoplasmic tail to control tumor Ag presentation by DCs.